After propensity-score matching, the two cohorts (25,820 in each cohort, mean age 58.0 years, 45.4% women, 14.8% Black, 61.2% White, 6.7% Hispanic) were balanced (Table 2)
Hippen: This recent attention to these class of medications and the diseases for which they're being treated can be redirected toward expanding access to RAS inhibition, which is an inexpensive and widely available and well vetted therapy for a wide variety of kidney diseases that would really be an excellent result and a necessary first step to then taking the second step in adding an SGLT2 inhibitor or a GLP1 agonist
This is particularly problematic for sermorelin users because the largest surge of growth hormone occurs during deep slow-wave sleep
We are hopeful that mRNA vaccines could not only improve outcomes for patients being treated with immunotherapies but also bring the benefits of these therapies to patients with treatment-resistant disease. A multi-center, randomized Phase III trial currently is being designed to validate these findings and investigate whether COVID mRNA vaccines should be part of the standard of care for patients receiving immune checkpoint inhibition
Patients enrolled in PlexusDx treatment access digital progress tracking, provider consultation, and optional Precision Peptide Genetic Testing at $99 as an add-on after the first month
